Skip to main content
. 2011 Aug;70(4-19):461–467. doi: 10.1016/j.diagmicrobio.2010.12.015

Table 6.

Characteristics of patients with S. suis meningitis confirmed by CSF and/or blood culture and PCR, or only confirmed by PCR

Characteristics CSF and/or blood culture and PCR positive (n = 67) PCR positive (n = 43) P valuea
General information
 Age, median (IQR) 48 (38–56) 53 (45–61) 0.026
 Male sex (n, %) 57 (85.1) 34 (79.1) 0.416
 Residence (rural) (n, %) 53 (79.1) 32 (74.41) 0.567
Underlying diseases and exposure
 Diabetes mellitus (n, %) 1 (1.5) 6 (13.0) 0.010
 Alcoholism (n, %) 8 (11.9) 2 (4.7) 0.194
 Pig exposure (n, %) 26 (38.8) 14 (32.6) 0.506
Clinical manifestations
 Days of illness, median (IQR) 3 (3–5) 5 (4–7) 0.004
 Antimicrobial therapy before admission (n, %) 35 (53.2) 38 (88.4) <0.001
 Fever (n, %) 65 (97.0) 42 (97.7) 0.522
 Headache (n, %) 67 (100) 42 (97.7) 0.391
 Nausea/vomiting (n, %) 49 (73.1) 27 (62.8) 0.252
 Neck stiffness (n, %) 61 (91.0) 40 (93.0) 1.000
 Glasgow Coma Score, median (IQR) 12 (9–14) 13 (9–15) 0.159
 Tinnitus (n, %) 50 (74.6) 27 (62.8) 0.118
 Deafness (n, %) 19 (28.4) 11 (25.6) 0.714
 Skin injuries (n, %) 18 (26.9) 13 (30.2) 0.702
 Herpes labialis (n, %) 29 (43.3) 21 (48.8) 0.568
Laboratory investigations median (IQR)
 ▪ Blood
   White blood cells (103/L) 18 000 (12 400–23 000) 16 840 (12 600–23 550) 0.941
   Neutrophil (%) 88 (83–91) 86.3 (80.3–90) 0.131
 ▪ CSF
   White cells (103/L) 1570 (760–3480) 1340 (340–2900) 0.153
   Neutrophil (%) 86 (74–91) 70 (49–85) 0.002
   Protein (g/L) 1.6 (1.3–2) 1.63 (1.2–2) 0.402
   CSF/blood glucose ratio 0.24 (0.15–0.31) 0.40 (0.29–0.5) <0.001
   Lactate (mmol/L) 11.2 (6.8–15.7) 5.73 (4.4–8.3) <0.001
Outcome (survival) 67 (100) 40 (100)b
a

Determined using Fisher exact test or Wilcoxon rank-sum test, as appropriate.

b

Three patients were transferred to other hospitals and their outcomes are unknown.